IVIEW Therapeutics Inc.
7 clinical trials · Sponsor
◉ Watch IVIEW Therapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis (NCT06463678) | IVIEW Therapeutics Inc. | 2026-08-01 |
| GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma (NCT06921317) | IVIEW Therapeutics Inc. | 2025-11-19 |
| Phase 2b Controlled Study of Dosing Techniques - Part B (NCT07161011) | IVIEW Therapeutics Inc. | 2025-09-08 |
| Phase 2b Controlled Study (NCT07140380) | IVIEW Therapeutics Inc. | 2025-08-20 |
| IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease (NCT06400459) | IVIEW Therapeutics Inc. | 2024-06-25 |
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis (NCT03749317) | IVIEW Therapeutics Inc. | 2023-02-20 |
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis (NCT05816070) | IVIEW Therapeutics Inc. | 2023-01-05 |
Track IVIEW Therapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.